Clinical-grade preventive intelligence
BioTwin aims to equip primary care and frontline clinics with AI-powered screening protocol research to support medical decision and stratify risk across 5 clinical domains and 15 health conditions. From simple at-home collection.
Patients join the journey through TwinMe, our consumer app for personalized health tracking.
BioTwin multi-omics approach integrates biological analysis, complete lifestyle & medical data into actionable clinical insights — enabling screening, longitudinal monitoring, and decision-support research outputs.
Current healthcare often intervenes too late, treats populations instead of individuals, and leaves prevention to chance.
No unified protocol covers multiple disease domains at once. Clinicians juggle disconnected screening tools with no shared view.
People only engage the system when symptoms appear. By then, early intervention windows have closed.
Comprehensive screening programs are expensive, time-consuming, and hard to repeat. Most clinics can't offer it at scale.
BioTwin integrates multi-omics and AI-driven models in research and pilot studies to explore how virtual twins can support future clinical decision tools.
AI-powered screening protocol research, unified dashboards, longitudinal monitoring, and structured triage support across 5 domains.
Through TwinMe, patients access their health data, track their progress, and stay connected to their care team.
BioTwin is being validated through clinical research and pilot collaborations, designed as a clinical decision-support (CDST) layer that augments physician judgment with longitudinal, multi-omic insights. It does not replace clinicians or provide standalone diagnoses. BioTwin is currently in research and validation phase and is not yet a clinically validated medical solution.
5 clinical domains. 15 health conditions.
BioTwin protocol aims to monitor biological signals, screen for meaningful deviations from each individual's baseline, and flag risk supporting clinical, triage and routing decisions. BioTwin does not replace physicians. BioTwin aims to provide a longitudinal decision-support research layer that strengthens primary-care workflows and reduces uncertainty, latency and diagnostic burden.
The BioTwin 5-10-15 Protocol aims to deliver a comprehensive biological scan of you, powered by your personal virtual twin. It combines multi-omic analysis (genomic, proteomic, metabolomic biomarkers), clinical and lifestyle assessments, and continuous data from wearables, apps, imaging, and medical records, alongside facial, skin, voice, and movement biomarkers. All signals aim to be unified into a continuously updated virtual twin, providing a 360-degree view of your health and how it evolves over time, not a one-time snapshot. 5 days. 10 drops. 15 health conditions.
Simple & effortless samples collection over 5 days, flexible to fit your schedule and capture biological variability.
Low-friction at-home collection using finger blood, urine, and saliva. No clinic visit required.
One unified view across five clinical domains: Oncology, Neurology, Cardiology, Lifestyle, and Life & Health Span.
Single measurements capture only a snapshot.
BioTwin's repeat sampling builds a personal biological baseline and detects meaningful change earlier — enabling smarter decisions over time.
Prepare for 2027 pilot deployment
Limited onboarding slots for primary-care partners
Begin collecting your biological baseline now. Protocol activation in 2027.
